© 2021 MJH Life Sciences and Neurology Live. All rights reserved.
© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Experts discuss the diagnosis and treatment of progressive multiple sclerosis.
March 18th 2021
A panel of experts led by Bruce Cree, MD, highlight the clinical subtypes of multiple sclerosis including presentation and prevalence.
An overview of the criteria used to diagnose relapsing-remitting multiple sclerosis when it converts to secondary progressive multiple sclerosis.
March 24th 2021
Fred D. Lublin, MD, leads a discussion about the different classifications of secondary progressive multiple sclerosis, including the relationship between disease activity and progression of disease.
March 25th 2021
A comparison of various factors considered when treating primary progressive multiple sclerosis versus secondary progressive multiple sclerosis.
April 1st 2021
Robert Fox, MD, discusses the rationale for using siponimod for the treatment of progressive multiple sclerosis as well as the practical implications of the phase 3 EXPAND trial.
Experts in the field of multiple sclerosis compare the results of the EXPAND study to the results of the ASCEND study.
April 8th 2021
Kristen Krysko, MD, summarizes the results of the phase III ORATORIO trial and discusses the rationale for using ocrelizumab for the treatment of progressive multiple sclerosis.
Experts in the field of multiple sclerosis discuss patient selection for drugs based on disease activity.
April 15th 2021
A discussion of how experts treat nonactive multiple sclerosis in terms of trial results or symptom management and how decisions are based on patient age.
Experts in progressive multiple sclerosis summarize the phase 2 SPRINT-MS trial and the rationale for treating patients with ibudilast.